This report contains market size and forecasts of Genome-Based Drug in global, including the following market information:
Global Genome-Based Drug Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Genome-Based Drug Market Sales, 2017-2022, 2023-2028, (Kiloton)
Global top five Genome-Based Drug companies in 2021 (%)
The global Genome-Based Drug market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Insulin Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Genome-Based Drug include Sandoz International, Teva pharmaceutical industries, Mylan, 3SBio, Shanghai Fosun Pharmaceutical, Tonghua Dongbao Pharmaceutical, Biocon, Reliance Life Sciences and Probiomed, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Genome-Based Drug manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Genome-Based Drug Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Kiloton)
Global Genome-Based Drug Market Segment Percentages, by Type, 2021 (%)
Insulin
Growth Hormone
Monoclonal Antibody
Other
Global Genome-Based Drug Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Kiloton)
Global Genome-Based Drug Market Segment Percentages, by Application, 2021 (%)
Hospital
Pharmaceutical Factory
Other
Global Genome-Based Drug Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Kiloton)
Global Genome-Based Drug Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Genome-Based Drug revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Genome-Based Drug revenues share in global market, 2021 (%)
Key companies Genome-Based Drug sales in global market, 2017-2022 (Estimated), (Kiloton)
Key companies Genome-Based Drug sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Sandoz International
Teva pharmaceutical industries
Mylan
3SBio
Shanghai Fosun Pharmaceutical
Tonghua Dongbao Pharmaceutical
Biocon
Reliance Life Sciences
Probiomed
Biosidus
AMEGA Biotech
Celltrion
LG Life Science
Dong-A Pharmaceutical